News for Basilea Pharmaceutica AG (BPMUF)

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NBSLN.S - Basilea Pharmaceutica AG AllschwilFull Year 2024 Basilea Pharmaceutica AG Allschwil E

Basilea Pharmaceutica AG (OTC:BPMUF) Q4 2024 Earnings Conference Call February 18, 2025 10:00 AM ETCompany ParticipantsDavid Veitch - Chief Executive...

Allschwil, 10. Oktober 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und...

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Basilea Pharmaceutica (BPMUF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Revenue: CHF73.3 million from Cresemba and ZEVTERA.Operating Result: CHF9.3 million.Net Profit: CHF20.7 million.Cresemba In-Market Sales: USD489 million, a 24%

Aug 13, 2024 / 02:00PM GMTDavid Veitch - Basilea Pharmaceutica AG Allschwil - Chief Executive Officer, Member of the Management Committee Thank you, and hello,

Basilea Pharmaceutica AG (OTC:BPMUF) Q2 2024 Results Conference Call August 13, 2024 10:00 AM ETCompany ParticipantsDavid Veitch - Chief Executive...

Allschwil, 20. Juni 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem...

If you are looking for stocks that are well positioned to maintain their recent uptrend, Basilea Pharmaceutica (BPMUF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Creating anti-infective opportunities Patients are at the heart of what we do Investor presentation ...

Dow Jones Newswires March 11, 2024 02:15 ET ...

Nov 13, 2023 / 03:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceutica Acquisition of Fosmanogepix Conference Call and Live Webcast. I am

Aug 15, 2023 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceuticals Half Year Results 2023 Conference Call and Live Webcast. I am Al

Aug 16, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceutica Half Year Results 2022 Conference Call and Live Webcast. I am Sand

Jun 28, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the webcast on the positive top line results of Phase III ERADICATE study in SAB. I'm Alice,

Read Head-To-Head Analysis: Basilea Pharmaceutica (OTCMKTS:BPMUF) versus Avalo Therapeutics (NASDAQ:AVTX) at ETF Daily News

Read Analysts’ Upgrades for June 2nd (BKHYY, BPMUF, CADL, CNI, CRDF, DELL, DPSI, DSP, EDU, EMX) at ETF Daily News